Reactivity in the Venereal Diseases Research Laboratory test and the Mercia® IgM enzyme immunoassay after treatment of early syphilis

International Journal of STD and AIDS

Volumn 19, Issue 10, 2008, Pages 689-693

  McMillan, A ^a   Young, H ^a,b  

^a Department of Genitourinary Medicine ^*

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Serodiagnosis; Syphilis; Treponemal infection

Indexed keywords

BENZATHINE PENICILLIN; DOXYCYCLINE; IMMUNOGLOBULIN M;

ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MONITORING; PRIORITY JOURNAL; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CARDIOLIPINS; DOXYCYCLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; PENICILLIN G, BENZATHINE; SENSITIVITY AND SPECIFICITY; SYPHILIS; SYPHILIS SERODIAGNOSIS; TIME FACTORS; TREATMENT OUTCOME; TREPONEMA PALLIDUM;

EID: 53549104426     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008104     Document Type: Article

References (10)

1. Brown ST, Zaidi A, Larsen SA, Reynolds GH. Serological response to syphilis treatment. A new analysis of old data. JAMA 1985;253: 1296-9
2. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Int Med 1991;114:1005-9
3. Geusau A, Kittler H, Hein U, Dangl-Erlach E, Stingl G, Tschachler E. Biological false-positive tests comprise a high proportion of Venereal Disease Research Laboratory reactions in an analysis of 300,000 sera. Int J STD AIDS 2005;16:722-6
4. Baker-Zander SA, Roddy RE, Handsfield HH, Lukehart SA. IgG and IgM antibody reactivity to antigens of Treponema pallidum after treatment of syphilis. Sex Transm Dis 1986;13:214-20
5. McMillan A, Young H. Qualitative and quantitative aspects of the serological diagnosis of early syphilis. Int J STD AIDS 2008;19:620-4
6. UK National Guidelines on the management of syphilis 2007 Draft 3. Clinical Effectiveness Group, British Association for Sexual Health and HIV. www.bashh.org/guidelines/draft/SyphilisGuideline2007Draft.pdf
7. Lefevre JC, Bertrand MA, Bauriaud R. Evaluation of the Captia enzyme immunoassays for detection of immunoglobulins G and M to Treponema pallidum in syphilis. J Clin Microbiol 1990;28:1704-7
8. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997;337:307-14
9. Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007;83:97-101
10. Jacobson DL, McCutchan JA, Spechko PL, et al. The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. J Infect Dis 1991;163:240-6